Management strategies in heart failure with preserved ejection fraction.

"Declarations Conflict of interestJ. Wintrich received speaker honoraria from Brystol Myers Squibb. M. Böhm is supported by the Deutsche Forschungsgemeinschaft (SFB TTR 219, S‑01 project number 322900939) and reports personal fees from Abbott, Amgen, Astra Zeneca, Bayer, Boehringer Ingelheim, Cytokinetics, Medtronic, Novartis, Servier and Vifor. A. Abdin declare that he has no competing interests. For this article no studies with human participants or animals were performed by any of the authors. All studies mentioned were in accordance with the ethical standards indicated in each case. Conflict of interest J. Wintrich received speaker honoraria from Brystol Myers Squibb. M. Böhm is supported by the Deutsche Forschungsgemeinschaft (SFB TTR 219, S‑01 project number 322900939) and reports personal fees from Abbott, Amgen, Astra Zeneca, Bayer, Boehringer Ingelheim, Cytokinetics, Medtronic, Novartis, Servier and Vifor. A. Abdin declare that he has no competing interests."

"Funding This work has not been funded."